AZN - AstraZeneca PLC

Your Recent Quotes: 0 | 0

AstraZeneca PLC

TRADE NOW Related Information and Financials
Price Glossary Definition
34.10 -0.64
-1.84%
11/21/08 4:02
Open
34.98
Prev Close
34.74
Volume
2,805,571
52 Wk. Range
32.58- 49.85
Year-to-Date Performance Glossary Definition
DOWN -20.36%
Latest Dividend
Dividend
0.55
Yield
5.47
Ex-Date
08/06/2008
Price/Earnings Comparisons Glossary Definition
 
9.29
 
8.90
 
12.60
AZN
Sect. Av.
S&P 500
Market Cap
50,246,650,600
Outstanding Shares
1,457,018,000
TheStreet Rating Glossary Definition
  • A
  • B
  • C
  • D
  • E
Buy AZN Rating Report
Target Price (1Yr)
High
61.00
Revenue
32.42B

Annual Dividend
Rate
1.10
Yield
3.20
Growth
12 Month
3 Year
CAGR
Revenue
11.60
0.38
0.11
Net Income
-7.40
0.59
0.16
EPS
-3.10
0.64
0.18

Stock Performance History
 
3 Month
1 Year
3 Year
Price Change
-29.52
-21.12
-23.75
Earnings Per Share($)

12/2005
 
 
 
2.91
12/2006
 
 
 
3.86
12/2007
 
 
 
3.74

Earnings
EBITDA
9.22B
Revenue
29.56B
Outside Analyst Rating History

11/22/08
1
Buy
11/22/08
7
Hold
11/22/08
1
Sell

Jim Cramer Portfolio
Find out now if AZN is in Jim's personal portfolio at Action Alerts PLUS.

Price & Volume

Compare This Stock
Latest Headlines
The company also said it was granted a temporary restraining order to halt the launch of a generic version of its Pulmicort medication by Teva.

7:17AM 11/20/08

The drug stock plunges after the company revised its forecast

7:20PM 11/19/08

OSI Pharmaceuticals is up 5.7%.

3:55PM 11/19/08

AstraZeneca presented data over the weekend at the American Heart Association meeting that could widen the use of its cholesterol drug Crestor as a preventive treatment.

9:59AM 11/10/08

AstraZeneca, Crown Castle and Ryder are downgraded.

2:53PM 11/08/08

A trader says it is time to show the stock some love.

6:40PM 10/16/08

The company won a favorable ruling in its patent case against Boston Scientific.

4:15PM 10/01/08

Amgen gains on positive denosumab study results.

4:45PM 09/16/08

ImClone says an unnamed bidder has topped Bristol-Myers' $60-a-share offer by $10 a share.

2:21PM 09/10/08

ImClone says an unnamed bidder has topped Bristol-Myers' $60-a-share offer by $10 a share.

11:50AM 09/10/08

Understanding the Market

Our Experts' Take at RealMoney
However, option traders boost January calls.

4:37PM 11/21/08

This market is producing a few stocks that could represent exceptional opportunities.

3:03PM 11/21/08

More Experts' Takes


Premium Stock Ideas
Is Cramer trading AZN in his Action Alerts Plus Portfolio?

Premium Services